Ajooni Biotech Ltd.
Snapshot View

54.95 +2.60 ▲5.0%

23 July 2021, 03:56:32 P.M.
Volume: 52,533

Overview View Details

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.ajoonibiotech.com
Financial Indicators
Market Cap 54.98 Cr.
Earnings per share (EPS) 0.37 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 147.80 Trailing Twelve Months Ending 2021-03
Industry PE 100.55 Trailing Twelve Months Ending 2021-03
Book Value / Share 15.46 Trailing Twelve Months Ending 2021-03
Price to Book Value 3.55 Calculated using Price: 54.95
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.00 Cr. 10,005,582 Shares
FaceValue 10
Company Profile

The company was originally incorporated at Chandigarh as ‘Ajooni Biotech Private Limited’ on February 17, 2010 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Consequent upon the conversion of the company to public limited company, the name of the company was changed to ‘Ajooni Biotech Limited’ and fresh certificate of incorporation dated September 27, 2017 was issued by the Registrar of Companies, Punjab & Chandigarh at Chandigarh.

The company is engaged in manufacturing, producing, processing and supplying of Cattle feed, Nutrients related to cattle feed and manufacturing & production of Animal health care supplements. They are registered with Department of Industries, Govt. of Punjab as Small Scale Industry (SSI) and also registered with Department of Dairy Development, Govt of Punjab. They have entered into an Agreement with Patanjali Gramudyog Nyas, Haridwar (Patanjali) (a unit of Yog Guru Baba Ramdev) for manufacturing of Cattle feed and Distribution of Cattle feed and feed supplements in their brand of Patanjali with 100% buy back arrangement for supplies in the states of Punjab, Himachal Pradesh, some parts of Jammu & Kashmir, Haryana and Rajasthan. 

Business area of the Company

The company is a paramount manufacturer and supplier of superior quality of Patanjali Samvriddhi, Patanjali Garbhanjali, Patanjali Batisa-Pro etc. The products offered by them are processed using quality ingredients sourced from the trustworthy vendors of the market. Their range is appreciated for their features such as hygiene, accurate composition and easy to use. The offered range is processed under Quality certified manufacturing unit. Their manufactured veterinary products find use in the treatment and cure of many diseases in animals. Besides, they also undertake contracts for analytical method developments and stability studies. Available in air tight & hygienic packs, these medicines are highly appreciated for their accurate composition, precise pH value, effectiveness and longer shelf life.

Major Events and Milestones:

  • 2010: Incorporation of the company in the name and style of ‘Ajooni Biotech Private Limited’.
  • 2013: Alteration in the Object Clause of Memorandum of Association of the Company.
  • 2015: Entered into business agreement with Patanjali Gramudyog Nayas, Maharishi Dayanand Gram (Haridwar).
  • 2016: Change of Registered office from Union Terriotory of Chandigarh to State of Punjab.
  • 2017: Acquisition of Trademarks from Ishneet Kaur vide agreement dated 4th September, 2017.
  • 2017: Conversion of the company into Public Limited Company.

 

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.97%
1 Week
+0.09%
1 Month
+0.18%
3 Month
+71.72%
6 Month
+87.54%
1 Year
+319.47%
2 Year
+440.31%
5 Year
8 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -13.89 4.28 18.72 20.38 36.98 6.80 3.72 2.54
Return on Capital Employed (%) -13.89 6.73 27.57 18.62 36.19 10.03 3.84 4.35
Return on Assets (%) -13.51 3.04 6.89 4.78 3.61 2.40 2.20 1.69

Balance Sheet View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 0 0 0 1 1 11 12 16
Non Curr. Liab. 0 4 2 4 1
Curr. Liab. 0 1 2 8 6 2 6
Minority Int.
Equity & Liab. 0 1 2 2 13 19 18 23
Non Curr. Assets 0 0 0 7 8 6 5
Curr. Assets 0 0 1 2 6 11 12 18
Misc. Exp. not W/O 1 0 0
Total Assets 0 1 2 2 13 19 18 23

Profit Loss View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 1 7 13 29 42 40 40
Other Income 0 0 0 0 0
Total Income 1 7 13 29 43 40 40
Total Expenditure -1 -7 -13 -28 -41 -39 -39
PBIDT 0 0 0 1 1 1 1
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0 0
Taxation 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 -5 -4
Cash Fr. Inv. 0 0 0 1 0
Cash Fr. Finan. 0 0 1 -1 3
Net Change 0 0 0 -5 -1
Cash & Cash Eqvt 0 0 0 0 1 0

Shareholding Pattern View Details

9 Qtrs 2018-09 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 62.50 56.33 57.04 46.23 46.23 49.04 52.44 51.64 51.64
Public 37.50 43.67 42.96 53.76 53.77 50.96 47.57 48.36 48.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 13 Jul 2021
Clarification - Financial Results
The Exchange has sought clarification from Ajooni Biotech Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Mon, 12 Jul 2021
Clarification - Financial Results
The Exchange has sought clarification from Ajooni Biotech Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Fri, 09 Jul 2021
Copy of Newspaper Publication
Ajooni Biotech Limited has informed the Exchange about Copy of Newspaper Publication

Technical Scans View Details

Fri, 23 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Strongly Outperforming Benchmark Index Strongly Outperforming Benchmark Index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
Close Crossing 50 EMA From Below Close Crossing 50 EMA From Below
Stochastic %K Crossing %D from Below Stochastic %K Crossing %D from Below

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Syngene International Ltd. 25,162.00 627.80 +0.1%
Quess Corp Ltd. 11,787.84 797.80 +1.6%
RattanIndia Enterprises Ltd. 8,860.35 64.10 +5.0%
SIS Ltd. 7,216.06 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. 6,962.60 265.70 +7.3%
TeamLease Services Ltd. 6,775.02 3,962.75 +3.4%
Just Dial Ltd. 6,044.08 969.10 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 59.32 627.80 +0.1%
Quess Corp Ltd. Consolidated 2021-03 203.67 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2021-03 0.00 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 19.75 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-03 0.00 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2021-03 87.42 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2021-06 47.47 969.10 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 8.91 627.80 +0.1%
Quess Corp Ltd. Consolidated 2021-03 5.03 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2021-03 104.43 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 4.19 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-03 -41.01 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2021-03 10.40 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2021-06 4.79 969.10 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Syngene International Ltd. Consolidated 2021-03 0.28 627.80 +0.1%
Quess Corp Ltd. Consolidated 2020-03 0.51 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.00 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 0.74 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -3.67 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2020-03 0.14 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2020-03 0.00 969.10 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 16.59 627.80 +0.1%
Quess Corp Ltd. Consolidated 2020-03 -16.80 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.24 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 23.02 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -225.08 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2020-03 6.75 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2020-03 24.85 969.10 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 15.40 627.80 +0.1%
Quess Corp Ltd. Consolidated 2020-03 -5.79 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.63 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 21.05 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -178.22 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2020-03 16.25 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2020-03 31.48 969.10 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 2,184.30 627.80 +0.1%
Quess Corp Ltd. Consolidated 2020-03 10,991.48 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2020-03 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 9,127.30 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 76.81 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2020-03 5,200.72 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2020-03 953.11 969.10 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 404.90 627.80 +0.1%
Quess Corp Ltd. Consolidated 2020-03 -418.05 797.80 +1.6%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.38 64.10 +5.0%
SIS Ltd. Consolidated 2021-03 366.66 491.80 -1.1%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -312.40 265.70 +7.3%
TeamLease Services Ltd. Consolidated 2020-03 37.06 3,962.75 +3.4%
Just Dial Ltd. Consolidated 2020-03 272.31 969.10 -1.2%